There is no cure or treatment for Geographic Atrophy (GA)—an advanced form of age-related macular degeneration. If you or your loved one has GA, consider participating in GA clinical research studies (Chroma or Spectri).
If you haven’t been diagnosed with GA but think you may have the disease, take this quick questionnaire and visit your retina specialist for a diagnosis.
If you’ve already been diagnosed with GA and are over the age of 50, you may be eligible to participate in the Chroma or Spectri clinical research studies.
Caring for a loved one with GA can be challenging, but there are a variety of tools and resources available that can help ease the burden.
Geographic Atrophy is an advanced form of age-related macular degeneration. It is a progressive, irreversible condition of the eye that causes severe vision loss. GA damages the part of the eye that is responsible for sight in the center of your field of vision.
The purpose of these studies is to understand the effects of an investigational drug called lampalizumab in reducing the speed of GA progression. Currently, two clinical research studies (Chroma and Spectri) are recruiting patients. Both studies are identical.
Both clinical research studies, Chroma and Spectri, are actively recruiting participants.
If you think you may have GA, make an appointment to see your retina specialist right away.
There are a variety of tools, devices, and other resources available to help make living with GA easier.